5 Biotech Stocks with Biggest Upside

Page 1 of 5

In this article, we discuss 5 biotech stocks with biggest upside. If you want to read our detailed discussion on the recent developments in the biotech industry, you can go directly to 10 Biotech Stocks with Biggest Upside

5. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Average Target Price: $58.91

Potential Upside: 110.1%

Number of Hedge Fund Holders: 29

Value of Hedge Fund Holdings: $265,427,670

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a Pasadena, California-based biotech company developing RNA interference (RNAi) therapies for rare diseases.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has a proprietary platform called Targeted RNAi Molecule (TRiM) created to provide tissue-specific targeting. Experts believe that the company has an attractive RNA interference (RNAi) portfolio and strong partnerships. Although Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is incurring operational losses, it has a runway of three-and-a-half years based on the current cash burn. The company has a target of having 20 products either in the clinical stage or in the market by 2025.

Page 1 of 5